MENU
BLSM BlossomHill Therapeutics Inc Forecast, Technical & Fundamental Analysis
BlossomHill Therapeutics Inc is a clinical-stage biopharmaceutical company applying its intentional, chemistry-based approach to develop small molecule medicines that address unmet medical needs in cancer treatment... Show more
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I. Advisor
published Earnings
BLSM is expected to report earnings to fall 89.37% to -93 cents per share on December 18
Q3'26
Est.
$-0.93
Q2'26
Missed
by $7.91
The last earnings report on September 18 showed earnings per share of -875 cents, missing the estimate of -83 cents. With 39.65K shares outstanding, the current market capitalization sits at 483.45M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DURA | 40.65 | 0.69 | +1.73% |
| VanEck Durable High Dividend ETF (DURA) | |||
| LSAF | 57.17 | 0.76 | +1.35% |
| LeaderShares AlphaFactor US Core Equity ETF (LSAF) | |||
| JHCR | 24.45 | 0.08 | +0.35% |
| John Hancock Core Bond ETF (JHCR) | |||
| SBAR | 25.18 | 0.06 | +0.24% |
| Simplify Barrier Income ETF | |||
| TQQY | 11.78 | -0.04 | -0.37% |
| GraniteShares YieldBOOST QQQ ETF (TQQY) | |||
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
10255 Science Center Drive
Phone
+1 858 732-3880
Employees
63
Web
https://www.bhtherapeutics.com